Description

Nitrogranulong Tablets with Prolonged Release 5.2 mg №50

Ingredients:

Each tablet contains 5.2 mg of Nitrogranulong with prolonged release.

Dosage:

The recommended dosage is one tablet daily, or as prescribed by a healthcare professional.

Indications:

Nitrogranulong tablets are indicated for the prevention and treatment of angina pectoris.

Contraindications:

Do not use Nitrogranulong tablets if you have hypotension, severe anemia, or are allergic to nitroglycerin.

Directions:

Swallow the tablet whole with water. Do not crush or chew the tablet.

Scientific Evidence:

Nitrogranulong tablets with prolonged release have been extensively studied for their efficacy in the management of angina pectoris. Research published in the Journal of Clinical Pharmacology demonstrated the significant reduction in the frequency and severity of angina attacks in patients treated with nitroglycerin formulations similar to Nitrogranulong.

Additional Information:

Nitrogranulong tablets provide a sustained release of nitroglycerin, ensuring prolonged therapeutic effects and improved patient compliance. Clinical trials have shown that the prolonged-release formulation of nitroglycerin leads to better symptom control and quality of life in angina patients compared to immediate-release formulations.